Abstract
This chapter describes a method to quantify biased signaling effects of agonists; this approach can furnish a scale for medicinal chemists to optimize biased profiles. Biased ligands have different pharmacological properties on a molecular level (stabilization of different receptor active states) and thus can have different pharmacological profiles therapeutically. The calculation of transduction ratios (ΔΔlog(τ/K A)) values (where τ is efficacy and K A a measure of affinity) allows the identification of agonists that demonstrate unique signaling either for different signaling pathways linked to the receptor, differences in cellular host, effects of receptor mutation, or receptor selectivity profiles. The procedure includes statistical methods to assess the significance of these effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kenakin TP, Watson C, Muniz-Medina V, Christopoulos A, Novick S (2012) A simple method for quantifying functional selectivity and agonist bias. ACS Chem Neurosci 3:193–203
Kenakin TP (1995) Agonist-receptor efficacy II: agonist-trafficking of receptor signals. Trends Pharmacol Sci 16:232–238
Mailman RB (2007) GPCR functional selectivity has therapeutic impact. Trends Pharmacol Sci 28:390–396
Perez DM, Karnick SS (2005) Multiple signaling states of G-protein coupled receptors. Pharmacol Rev 57:147–161
Kenakin T (2013) New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2. Br J Pharmacol 168(3):554–575
Kenakin TP, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62:265–304
Liu JJ et al (2012) Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science 335:1106–1110
Tilley DG (2011) G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function. Circ Res 109:217–230
Tilley DG (2011) Functional relevance of biased signaling at the angiotensin II type 1 receptor. Endocr Metab Immune Disord Drug Targets 11:99–111
Urban JD, Vargas GA, von Zastrow M, Mailman RB (2007) Aripiprazole has functionally selective action at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32:67–77
Bohn L, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin F-T (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495–2498
Bohn LM, Schmid CL (2010) Serotonin receptor signaling and regulation via β-arrestins. Crit Rev Biochem Mol Biol 45:555–566
DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta arrestins and cell signaling. Annu Rev Physiol 69:483–510
Gesty-Palmer D, Flannery P, Yaun L et al (2009) A β-arrestin–biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 1:1ra1
Ehlert FJ (2005) Analysis of allosterism in functional assays. J Pharmacol Exp Ther 315:740–754
Figueroa KW et al (2009) Selectivity of agonists for the active state of the M1 to M4 muscarinic receptor subtypes. J Pharmacol Exp Ther 328:331–342
Tran JA et al (2009) Estimation of the relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors. Mol Pharmacol 75:381–396
Black JW, Leff P (1983) Operational models of pharmacological agonist. Proc R Soc Lond Biol 220:141–162
Black JW, Leff P, Shankley NP (Appendix J. Wood) (1985) An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84:561–571
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kenakin, T. (2015). The Measurement of Receptor Signaling Bias. In: Filizola, M. (eds) G Protein-Coupled Receptors in Drug Discovery. Methods in Molecular Biology, vol 1335. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2914-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2914-6_11
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2913-9
Online ISBN: 978-1-4939-2914-6
eBook Packages: Springer Protocols